Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation + Lenvatinib + QL1706 in Advanced ICC
NCT07070700Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of iparomlimab + tuvonralimab in intrahepatic cholangiocarcinoma (ICC), sponsored by Fudan University. Started Aug 2025; status: recruiting.
02
Drugs
iparomlimab + tuvonralimab
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT07070700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07070700.